Corona's new Vaccine || Treatment Trial Begins || Total Coronavirus Cases Worldwide more than 5.4 million victims

A team of medical researchers in the UK has begun recruiting volunteers for clinical trials of the COVID-19 vaccine, while another team has begun testing a treatment that could save the lives of critically ill patients with coronavirus

The research on the corona virus vaccine, which began in January this year, was carried out by the Oxford University's Jenner Institute in collaboration with the Oxford Vaccine Group.

According to Arab News, scientists are now recruiting more than 10,000 volunteers for further clinical trials of the vaccine, following initial trials in April.

The researchers initially conducted clinical trials on 160 people, after which more people from different regions and ages will be included in the trials to determine the effectiveness of the vaccine.

The vaccine was developed using the corona virus, the SARS virus, and a 'mutated virus' that infects humans.

According to researchers, animal experiments have shown positive effects of this vaccine

The vaccine will now be given to trial participants with a licensed vaccine called 'Main ACWY', which is used to prevent meningitis and blood poisoning. Although more than 100 vaccines are being tested worldwide, this vaccine is one of four vaccines that are undergoing large-scale trials around the world.

Large-scale production of the vaccine is already underway in the hope that trials will be successful. The Oxford team says about one million units of the vaccine are expected to be ready for use by September. This week, pharmaceutical company AstraZeneca said it had the capacity to produce one billion doses of the Oxford vaccine and had agreed to produce at least 400 million doses.

Meanwhile, scientists working at King's College London, Francis Kirk Institute and Guy and St. Thomas Hospital have begun a clinical trial of a drug called enteroloquine 7 to treat the corona virus. According to scientists, the people who are most exposed to the disease have a very small number of immune cells called T cells. Clinical trials will show whether this drug, which increases the number of T cells (interleukin 7), can help patients recover.

According to Johns Hopkins University in the United States, the number of people infected with the corona virus worldwide has exceeded 5.405 million, while the number of deaths due to COVID-19 is 343,982.

The highest number of deaths from the virus was 98,683 in the United States, with more than 1.6 million infected.